Mithril Capital Management leads Fractyl Laboratories Series C

Mithril Capital Management has led a $40 million Series C financing in health innovator Fractyl Laboratories. Existing investors General Catalyst, Bessemer and Domain Associates also participated.

8 September 2014•7 mins read
Feature image
LinkedInXEmail
LinkedInXEmail